![David Dodds](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David Dodds
Presidente presso Sucampo Pharma Europe Ltd.
Relazioni attive
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Gayle Robert Dolecek | M | 81 |
Sucampo Pharma Europe Ltd.
![]() Sucampo Pharma Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Mallinckrodt Plc, Sucampo Pharma Europe Ltd. is a British company that develops therapies for gastrointestinal, circulatory, and ophthalmic diseases. The company is based in London, UK. Sucampo Pharma Europe was acquired by Sucampo Pharmaceuticals LLC, part of Mallinckrodt Plc from February 14, 2018 on September 28, 2006. | 16 anni |
Andrew Smith | M | 61 |
Sucampo Pharma Europe Ltd.
![]() Sucampo Pharma Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Mallinckrodt Plc, Sucampo Pharma Europe Ltd. is a British company that develops therapies for gastrointestinal, circulatory, and ophthalmic diseases. The company is based in London, UK. Sucampo Pharma Europe was acquired by Sucampo Pharmaceuticals LLC, part of Mallinckrodt Plc from February 14, 2018 on September 28, 2006. | 13 anni |
Grafico relazionale
Relazione in diverse aziende
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Regno Unito | 2 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- David Dodds
- Contatti personali